Impact of marketing costs and the research and development on the profitability of Egypt's pharmaceutical companies | ||
| المجلة العلمية للدراسات المحاسبية | ||
| Article 9, Volume 1, العدد الثانى, March 2019, Pages 40-69 PDF (445.19 K) | ||
| Document Type: المقالة الأصلية | ||
| DOI: 10.21608/sjar.2019.110146 | ||
| Authors | ||
| Bassant Badr Eldin Abdo Abdo1; Walid Aboubakr Aboubakr2 | ||
| 1(Cairo University, Egypt) | ||
| 2International Academy of Engineering and media Sciences, Egypt | ||
| Abstract | ||
| The main objective of this study is to examine the impact of marketing and R&D expenditures on the competitiveness of Egypt's pharmaceutical companies. In this report, Egypt Stock Exchange admitted pharmaceutical companies. Data estimator random-effect panel was used for this purpose. The results indicate that variables such as the size of a business, the capital-to-total ratio of assets and the debt-to-asset ratio affect profitability. Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful. Legal concerns such as the absence of patent law and the framework for pricing are reasons for the poor partnership between R&D and marketing costs and its effect on income, The results indicate that variables such as the size of a business, the capital--ratio of assets and the debt--ratio affect profitability. Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful. Regulatory problems including the lack of & absence of patent law and pricing controls are reasons for the poor partnership between R&D and marketing costs and its impact on the Egyptian pharmaceutical industry's profitability. | ||
Highlights | ||
| ||
| Keywords | ||
| marketing costs; Research and development; profitability; pharmaceutical companies | ||
| Full Text | ||
|
| ||
| References | ||
|
| ||
|
Statistics Article View: 361 PDF Download: 942 |
||
